R Michael Carruthers's Net Worth
$1.85 Million
Who is R Michael Carruthers?
R Michael Carruthers has an estimated net worth of $1.85 Million. This is based on reported shares across multiple companies, which include Nivalis Therapeutics, Inc., Edgewise Therapeutics, Inc., Elevation Oncology, Inc., and Brickell Biotech, Inc..
SEC CIK
R Michael Carruthers's CIK is 0001644467
Past Insider Trading and Trends
2024 was R Michael Carruthers's most active year for acquiring shares with 5 total transactions. R Michael Carruthers's most active month to acquire stocks was the month of July. 2024 was R Michael Carruthers's most active year for disposing of shares, totalling 4 transactions. R Michael Carruthers's most active month to dispose stocks was the month of April. 2024 saw R Michael Carruthers paying a total of $173,700.00 for 292,083 shares, this is the most they've acquired in one year. In 2024 R Michael Carruthers cashed out on 187,365 shares for a total of $1,460,547.87, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nivalis Therapeutics, Inc. (ALPN) No price found
Interim President / CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
∞
| 24K |
$2.09 | $50,256.00 | 24K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Edgewise Therapeutics, Inc. (EWTX) Snapshot price: $17.52
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,013.90% | 70K |
$0.71 | $49,700.00 | 76.9K |
Oct 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
| +9.48% | 3.05K |
$18.91 | -$40,788.87 | 35.23K |
May 1 - May 2
| |||
Form 4
|
—
|
0
|
$8.86 | -$1,246,059.00 | 29.02K |
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
| +52.57% | 10K |
$0.71 | $7,100.00 | 29.02K |
Jun 22
| |||
Form 4
| +31.60% | 3.87K |
$8.90 | -$11,896.95 | 16.13K |
May 1 - May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 4
| +300.00% | 9K |
$0.71 | $6,390.00 | 12K |
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Elevation Oncology, Inc. (ELEV) Snapshot price: $0.6896
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Brickell Biotech, Inc. (FRTX) Snapshot price: $0.95
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||